Structure of the toxic core of α-synuclein from invisible crystals
- PMID: 26352473
- PMCID: PMC4791177
- DOI: 10.1038/nature15368
Structure of the toxic core of α-synuclein from invisible crystals
Abstract
The protein α-synuclein is the main component of Lewy bodies, the neuron-associated aggregates seen in Parkinson disease and other neurodegenerative pathologies. An 11-residue segment, which we term NACore, appears to be responsible for amyloid formation and cytotoxicity of human α-synuclein. Here we describe crystals of NACore that have dimensions smaller than the wavelength of visible light and thus are invisible by optical microscopy. As the crystals are thousands of times too small for structure determination by synchrotron X-ray diffraction, we use micro-electron diffraction to determine the structure at atomic resolution. The 1.4 Å resolution structure demonstrates that this method can determine previously unknown protein structures and here yields, to our knowledge, the highest resolution achieved by any cryo-electron microscopy method to date. The structure exhibits protofibrils built of pairs of face-to-face β-sheets. X-ray fibre diffraction patterns show the similarity of NACore to toxic fibrils of full-length α-synuclein. The NACore structure, together with that of a second segment, inspires a model for most of the ordered portion of the toxic, full-length α-synuclein fibril, presenting opportunities for the design of inhibitors of α-synuclein fibrils.
Figures
Comment in
-
Parkinson's disease: Crystals of a toxic core.Nature. 2015 Sep 24;525(7570):458-9. doi: 10.1038/nature15630. Epub 2015 Sep 9. Nature. 2015. PMID: 26352470 No abstract available.
-
Invisible Killers.Mov Disord. 2016 Jan;31(1):44. doi: 10.1002/mds.26465. Epub 2016 Jan 9. Mov Disord. 2016. PMID: 26748962 No abstract available.
Similar articles
-
Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases.J Biol Chem. 2005 Nov 18;280(46):38609-16. doi: 10.1074/jbc.M508623200. Epub 2005 Sep 14. J Biol Chem. 2005. PMID: 16162499
-
α-Synuclein Amyloid Fibrils with Two Entwined, Asymmetrically Associated Protofibrils.J Biol Chem. 2016 Jan 29;291(5):2310-8. doi: 10.1074/jbc.M115.698787. Epub 2015 Dec 7. J Biol Chem. 2016. PMID: 26644467 Free PMC article.
-
Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy.Cell Res. 2018 Sep;28(9):897-903. doi: 10.1038/s41422-018-0075-x. Epub 2018 Jul 31. Cell Res. 2018. PMID: 30065316 Free PMC article.
-
New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy.Curr Opin Neurobiol. 2020 Apr;61:89-95. doi: 10.1016/j.conb.2020.01.014. Epub 2020 Feb 26. Curr Opin Neurobiol. 2020. PMID: 32112991 Review.
-
Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.Ann N Y Acad Sci. 2005 Dec;1066:181-221. doi: 10.1196/annals.1363.030. Ann N Y Acad Sci. 2005. PMID: 16533927 Review.
Cited by
-
Amyloid-Like Aggregation in Diseases and Biomaterials: Osmosis of Structural Information.Front Bioeng Biotechnol. 2021 Mar 3;9:641372. doi: 10.3389/fbioe.2021.641372. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 33748087 Free PMC article. Review.
-
Distinct C9orf72-Associated Dipeptide Repeat Structures Correlate with Neuronal Toxicity.PLoS One. 2016 Oct 24;11(10):e0165084. doi: 10.1371/journal.pone.0165084. eCollection 2016. PLoS One. 2016. PMID: 27776165 Free PMC article.
-
Brain clearance of protein aggregates: a close-up on astrocytes.Mol Neurodegener. 2024 Jan 16;19(1):5. doi: 10.1186/s13024-024-00703-1. Mol Neurodegener. 2024. PMID: 38229094 Free PMC article. Review.
-
Advances in methods for atomic resolution macromolecular structure determination.F1000Res. 2020 Jul 2;9:F1000 Faculty Rev-667. doi: 10.12688/f1000research.25097.1. eCollection 2020. F1000Res. 2020. PMID: 32676184 Free PMC article. Review.
-
The Evolution and the Advantages of MicroED.Front Mol Biosci. 2018 Dec 12;5:114. doi: 10.3389/fmolb.2018.00114. eCollection 2018. Front Mol Biosci. 2018. PMID: 30619880 Free PMC article. Review.
References
-
- Spillantini MG, et al. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839–840. - PubMed
-
- Goedert M, Spillantini MG, Del Tredici K, Braak H. 100 years of Lewy pathology. Nat. Rev. Neurol. 2013;9:13–24. - PubMed
-
- Polymeropoulos MH, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045–2047. - PubMed
-
- Krüger R. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat. Genet. 1998;18:106–108. - PubMed
-
- Zarranz JJ, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 2004;55:164–173. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
Grants and funding
- R01 AG029430/AG/NIA NIH HHS/United States
- R01 GM102520/GM/NIGMS NIH HHS/United States
- P41 GM103403/GM/NIGMS NIH HHS/United States
- AG016570/AG/NIA NIH HHS/United States
- GM095887/GM/NIGMS NIH HHS/United States
- T32 GM007185/GM/NIGMS NIH HHS/United States
- R01 GM095887/GM/NIGMS NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- P50 AG016570/AG/NIA NIH HHS/United States
- GM102520/GM/NIGMS NIH HHS/United States
- 1R01-AG029430/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
